These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
287 related articles for article (PubMed ID: 18084683)
41. Preclinical properties of 18F-AV-45: a PET agent for Abeta plaques in the brain. Choi SR; Golding G; Zhuang Z; Zhang W; Lim N; Hefti F; Benedum TE; Kilbourn MR; Skovronsky D; Kung HF J Nucl Med; 2009 Nov; 50(11):1887-94. PubMed ID: 19837759 [TBL] [Abstract][Full Text] [Related]
42. High detection sensitivity with antibody-based PET radioligand for amyloid beta in brain. Fang XT; Hultqvist G; Meier SR; Antoni G; Sehlin D; Syvänen S Neuroimage; 2019 Jan; 184():881-888. PubMed ID: 30300753 [TBL] [Abstract][Full Text] [Related]
43. Antibody-Based In Vivo PET Imaging Detects Amyloid-β Reduction in Alzheimer Transgenic Mice After BACE-1 Inhibition. Meier SR; Syvänen S; Hultqvist G; Fang XT; Roshanbin S; Lannfelt L; Neumann U; Sehlin D J Nucl Med; 2018 Dec; 59(12):1885-1891. PubMed ID: 29853653 [TBL] [Abstract][Full Text] [Related]
44. Preclinical characterization of a novel class of 18F-labeled PET tracers for amyloid-β. Brockschnieder D; Schmitt-Willich H; Heinrich T; Varrone A; Gulyás B; Toth M; Andersson J; Boemer U; Krause S; Friebe M; Dinkelborg L; Halldin C; Dyrks T J Nucl Med; 2012 Nov; 53(11):1794-801. PubMed ID: 23008501 [TBL] [Abstract][Full Text] [Related]
45. Novel (E)-5-styryl-2,2'-bithiophene derivatives as ligands for β-amyloid plaques. Cui M; Li Z; Tang R; Jia H; Liu B Eur J Med Chem; 2011 Jul; 46(7):2908-16. PubMed ID: 21531050 [TBL] [Abstract][Full Text] [Related]
46. Synthesis and evaluation of novel ¹⁸F labeled 2-pyridinylbenzoxazole and 2-pyridinylbenzothiazole derivatives as ligands for positron emission tomography (PET) imaging of β-amyloid plaques. Cui M; Wang X; Yu P; Zhang J; Li Z; Zhang X; Yang Y; Ono M; Jia H; Saji H; Liu B J Med Chem; 2012 Nov; 55(21):9283-96. PubMed ID: 22974116 [TBL] [Abstract][Full Text] [Related]
47. 18F-labeled flavones for in vivo imaging of beta-amyloid plaques in Alzheimer's brains. Ono M; Watanabe R; Kawashima H; Kawai T; Watanabe H; Haratake M; Saji H; Nakayama M Bioorg Med Chem; 2009 Mar; 17(5):2069-76. PubMed ID: 19201614 [TBL] [Abstract][Full Text] [Related]
48. Low background and high contrast PET imaging of amyloid-β with [11C]AZD2995 and [11C]AZD2184 in Alzheimer's disease patients. Forsberg A; Juréus A; Cselényi Z; Eriksdotter M; Freund-Levi Y; Jeppsson F; Swahn BM; Sandell J; Julin P; Schou M; Andersson J; Johnström P; Varnäs K; Halldin C; Farde L; Svensson S Eur J Nucl Med Mol Imaging; 2013 Apr; 40(4):580-93. PubMed ID: 23324871 [TBL] [Abstract][Full Text] [Related]
49. [Development of SPECT Probes for In Vivo Imaging of β-Amyloid and Tau Aggregates in the Alzheimer's Disease Brain]. Watanabe H Yakugaku Zasshi; 2017; 137(11):1361-1365. PubMed ID: 29093372 [TBL] [Abstract][Full Text] [Related]
50. Radiation dosimetry and biodistribution of the beta-amyloid plaque imaging tracer 11C-BTA-1 in humans. Thees S; Neumaier B; Glatting G; Deisenhofer S; von Arnim CA; Reske SN; Mottaghy FM Nuklearmedizin; 2007; 46(5):175-80. PubMed ID: 17938750 [TBL] [Abstract][Full Text] [Related]
51. Novel anilinophthalimide derivatives as potential probes for beta-amyloid plaque in the brain. Duan XH; Qiao JP; Yang Y; Cui MC; Zhou JN; Liu BL Bioorg Med Chem; 2010 Feb; 18(3):1337-43. PubMed ID: 20036557 [TBL] [Abstract][Full Text] [Related]
53. Synthesis and evaluation of 18F-fluoroethylated benzothiazole derivatives for in vivo imaging of amyloid plaques in Alzheimer's disease. Neumaier B; Deisenhofer S; Sommer C; Solbach C; Reske SN; Mottaghy F Appl Radiat Isot; 2010 Jun; 68(6):1066-72. PubMed ID: 20089413 [TBL] [Abstract][Full Text] [Related]
54. Diphenylpropynone derivatives as probes for imaging β-amyloid plaques in Alzheimer's brains. Ono M; Watanabe H; Watanabe R; Haratake M; Nakayama M; Saji H Bioorg Med Chem Lett; 2011 Jan; 21(1):117-20. PubMed ID: 21145738 [TBL] [Abstract][Full Text] [Related]
55. Synthesis and evaluation of two 18F-labeled 6-iodo-2-(4'-N,N-dimethylamino)phenylimidazo[1,2-a]pyridine derivatives as prospective radioligands for beta-amyloid in Alzheimer's disease. Cai L; Chin FT; Pike VW; Toyama H; Liow JS; Zoghbi SS; Modell K; Briard E; Shetty HU; Sinclair K; Donohue S; Tipre D; Kung MP; Dagostin C; Widdowson DA; Green M; Gao W; Herman MM; Ichise M; Innis RB J Med Chem; 2004 Apr; 47(9):2208-18. PubMed ID: 15084119 [TBL] [Abstract][Full Text] [Related]
57. Preliminary Characterization and In Vivo Studies of Structurally Identical (18)F- and (125)I-Labeled Benzyloxybenzenes for PET/SPECT Imaging of β-Amyloid Plaques. Yang Y; Zhang X; Cui M; Zhang J; Guo Z; Li Y; Zhang X; Dai J; Liu B Sci Rep; 2015 Jul; 5():12084. PubMed ID: 26170205 [TBL] [Abstract][Full Text] [Related]
58. Design, synthesis, and preliminary evaluation of [ He Y; Zhu X; Wang K; Xie J; Zhu Z; Ni M; Wang S; Xie Q Bioorg Med Chem; 2022 Dec; 75():117087. PubMed ID: 36356533 [TBL] [Abstract][Full Text] [Related]
59. Fusion of hIgG1-Fc to 111In-anti-amyloid single domain antibody fragment VHH-pa2H prolongs blood residential time in APP/PS1 mice but does not increase brain uptake. Rotman M; Welling MM; van den Boogaard ML; Moursel LG; van der Graaf LM; van Buchem MA; van der Maarel SM; van der Weerd L Nucl Med Biol; 2015 Aug; 42(8):695-702. PubMed ID: 25960433 [TBL] [Abstract][Full Text] [Related]
60. Antibody engagement with amyloid-beta does not inhibit [ Xiong M; Dahlén A; Roshanbin S; Wik E; Aguilar X; Eriksson J; Sehlin D; Syvänen S J Neurochem; 2024 Sep; 168(9):2601-2610. PubMed ID: 38721627 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]